U.S. Patent No. 8,629,111

7 opinions in this collection construe or address U.S. Patent No. 8,629,111. View the patent on Google Patents.

• April 10, 2017 E.D. Tex. Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Apr. 10, 2017) Granted in Part
• January 12, 2017 E.D. Tex. Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Jan. 12, 2017) Granted
• January 12, 2017 E.D. Tex. Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Jan. 12, 2017) Denied
• December 13, 2016 E.D. Tex. Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Dec. 13, 2016) Claims Construed
• April 19, 2016 E.D. Tex. Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Apr. 19, 2016) Denied
• December 23, 2014 E.D. Tex. Allergan, Inc. v. Actavis plc et al, No. 2:14-cv-00638 (E.D. Tex. Dec. 23, 2014) Granted in Part
• December 23, 2014 E.D. Tex. Allergan, Inc. v. Actavis plc et al, No. 2:14-cv-00188 (E.D. Tex. Dec. 23, 2014) Granted in Part